AstraZeneca LP v. Mylan Pharmaceuticals Inc.
1:15-cv-01000
Overview
Parties
Defendant
Apotex Corp. Operating Company
Represented By
7 Attorneys ListedWhiteford
Whiteford, 600 North King Street
White & Williams
White & Williams, 600 North King Street, Suite 800
Apotex Inc. Operating Company
Represented By
2 Attorneys ListedWhiteford
Whiteford, 600 North King Street
White & Williams
White & Williams, 600 North King Street, Suite 800
Prinston Pharmaceutical Inc. Operating Company
Represented By
7 Attorneys ListedRichards, Layton & Finger
Richards, Layton & Finger, 920 North King Street
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Amneal Pharmaceuticals of New York LLC Operating Company
Represented By
7 Attorneys ListedYoung, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Young, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Young, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Amneal Pharmaceuticals LLC Operating Company
Represented By
7 Attorneys ListedYoung, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Young, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Young, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Watson Laboratories Inc. Operating Company
Represented By
11 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Mylan Pharmaceuticals Inc. Operating Company
Represented By
9 Attorneys ListedDevlin Law Firm
1526 Gilpin Avenue, 19806
Young, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
HEC Pharm USA NPE (Individual / Inventor)
Represented By
5 Attorneys ListedGould & Ratner LLP
222 N. LaSalle Street, Suite 800
McKool Smith
McKool Smith, 600 Travis Street
ADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 655-5000
Bayard, P.A.
Bayard, P.A., 600 N. King Street
HEC Pharm Co. Ltd. Operating Company
Represented By
8 Attorneys ListedGould & Ratner LLP
222 N. LaSalle Street, Suite 800
McKool Smith
McKool Smith, 600 Travis Street
ADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 655-5000
Bayard, P.A.
Bayard, P.A., 600 N. King Street
Plaintiff
AstraZeneca Pharmaceuticals, LP NPE (Individual / Inventor)
Represented By
4 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
AstraZeneca LP NPE (Individual / Inventor)
Represented By
3 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
AstraZeneca UK Limited NPE (University / Research)
Represented By
4 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
AstraZeneca AB NPE (Individual / Inventor)
Represented By
9 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Counter Claimant
HEC Pharm Group Operating Company
Represented By
4 Attorneys ListedGould & Ratner LLP
222 N. LaSalle Street, Suite 800
ADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 655-5000
Bayard, P.A.
Bayard, P.A., 600 N. King Street
Sandoz Inc. Operating Company
Represented By
5 Attorneys ListedPhillips, Goldman, McLaughlin & Hall, P.A.
Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street
Phillips, McLaughlin & Hall, P.A.
Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 2 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 6,251,910 Asserted | Asserted Patent | View Official Patent → |
| 🌐 PCT International (WIPO) | WO 1999005143 A1 | PCT World Application | View Official Patent → |
AstraZeneca LP v. Watson Laboratories Inc.
AstraZeneca LP v. Amneal Pharmaceuticals LLC
AstraZeneca LP v. Prinston Pharmaceutical Inc.
AstraZeneca LP v. Micro Labs Limited
AstraZeneca LP v. Watson Laboratories, Inc.
AstraZeneca LP v. Alembic Pharmaceuticals LTD
AstraZeneca LP v. InvaGen Pharmaceuticals Inc.
Patents Involved
There are 6 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6251910
1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists
|
Filed: 1998-07-15
Issued: 2001-06-26
|
Expired (Term Ended)
Expires: 2018-07-15
|
|
|
US6525060
Triazolo(4,5-d)pyrimidine compounds
|
Filed: 1999-12-02
Issued: 2003-02-25
|
Expired (Term Ended)
Expires: 2019-12-02
|
|
|
US7250419
Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
|
Filed: 2005-09-21
Issued: 2007-07-31
|
Expired (Term Ended)
Expires: 2025-09-21
|
|
|
US7265124
Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compound
|
Filed: 2005-10-03
Issued: 2007-09-04
|
Expired (Term Ended)
Expires: 2021-07-09
|
|
|
US8425934
Pharmaceutical compositions
|
Filed: 2007-08-20
Issued: 2013-04-23
|
Active (3.4 yrs remaining)
+971d PTA
Expires: 2030-04-17
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
86
Dispositive
19
Granted
0
Denied
0
Pending / Review
61
Motions by Category
Key Dispositive Motions & Rulings